Alpha 2.0
Login Register
» Articles » PMID: 18218143

Diffuse Idiopathic Pulmonary Neuroendocrine Cell Hyperplasia (DIPNECH) in Association with an Adenocarcinoma: a Case Report

Overview
Journal J Med Case Rep
Publisher Biomed Central
Specialty General Medicine
Date 2008 Jan 26
PMID 18218143
Citations 12
Authors
Arne Warth
Esther Herpel
Astrid Schmahl
Konstantina Storz
Philipp A Schnabel
Affiliations
Soon will be listed here.
Abstract

Introduction: Diffuse idiopathic pulmonary neuroendocrine cell hyperplasia (DIPNECH) is a rare disorder and information on this disease is limited, especially with regard to its management and prognosis. It has become generally accepted that DIPNECH is a precursor lesion to pulmonary carcinoid tumors.

Case Presentation: Here we report on a 60-year-old female patient with DIPNECH and an associated pulmonary adenocarcinoma.

Conclusion: This case contributes to a better understanding of the disorder and its associated pathologies.

Citing Articles

Coexistence of DIPNECH with pulmonary adenocarcinoma: Coincidence or by design?.

Song X, Cao Q, Liu W, Zhang Y, Hao J Heliyon. 2024; 10(20):e39406.

PMID: 39498006 PMC: 11534178. DOI: 10.1016/j.heliyon.2024.e39406.

Lung adenocarcinoma coexisting with diffuse idiopathic pulmonary neuroendocrine cell hyperplasia manifesting as multiple pulmonary nodules: A case report.

Inomata S, Matsumura Y, Kobayashi Y, Yamaguchi H, Watanabe M, Ozaki Y Thorac Cancer. 2022; 13(21):3076-3079.

PMID: 36134429 PMC: 9626319. DOI: 10.1111/1759-7714.14662.

DIPNECH: Association Between Histopathology and Clinical Presentation.

Trisolini R, Valentini I, Tinelli C, Ferrari M, Guiducci G, Forti Parri S Lung. 2016; 194(2):243-7.

PMID: 26880164 DOI: 10.1007/s00408-016-9854-7.

[Diagnosis, prognosis, and prediction of non-small cell lung cancer. Importance of morphology, immunohistochemistry and molecular pathology].

Warth A Pathologe. 2015; 36 Suppl 2:194-200.

PMID: 26391251 DOI: 10.1007/s00292-015-0085-0.

Lung cancer: developments, concepts, and specific aspects of the new WHO classification.

Petersen I, Warth A J Cancer Res Clin Oncol. 2015; 142(5):895-904.

PMID: 26197868 DOI: 10.1007/s00432-015-2004-4.

References
1.
Ruffini E, Bongiovanni M, Cavallo A, Filosso P, Giobbe R, Mancuso M . The significance of associated pre-invasive lesions in patients resected for primary lung neoplasms. Eur J Cardiothorac Surg. 2004; 26(1):165-72. DOI: 10.1016/j.ejcts.2004.03.044. View
2.
Kerr K . Pulmonary preinvasive neoplasia. J Clin Pathol. 2001; 54(4):257-71. PMC: 1731391. DOI: 10.1136/jcp.54.4.257. View
3.
Ge Y, Eltorky M, Ernst R, Castro C . Diffuse idiopathic pulmonary neuroendocrine cell hyperplasia. Ann Diagn Pathol. 2007; 11(2):122-6. DOI: 10.1016/j.anndiagpath.2005.12.008. View
4.
Gosney J . Diffuse idiopathic pulmonary neuroendocrine cell hyperplasia as a precursor to pulmonary neuroendocrine tumors. Chest. 2004; 125(5 Suppl):108S. DOI: 10.1378/chest.125.5_suppl.108s. View
5.
Davies S, Gosney J, Hansell D, Wells A, du Bois R, Burke M . Diffuse idiopathic pulmonary neuroendocrine cell hyperplasia: an under-recognised spectrum of disease. Thorax. 2006; 62(3):248-52. PMC: 2117154. DOI: 10.1136/thx.2006.063065. View